Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Setnikar

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Arzneimittel-Forschung|September 14, 1999
Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patchI Setnikar, L C Rovati, A Santoro, et al.
Arzneimittel-Forschung|October 1, 1987
Anticholecystokinin activities of loxiglumideI Setnikar, M Bani, R Cereda, et al.
Arzneimittel-Forschung|January 1, 1979
Studies on the mechanism of action of protacine (CR 604), a new non-steroidal anti-inflammatory agentR R Vidal y Plana, F Makovec, A Cifarelli, et al.
Arzneimittel-Forschung|December 22, 1999
Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studiesL C Rovati, K Schmid, G Giacovelli, et al.
Arzneimittel-Forschung|July 1, 1997
Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrixI Setnikar, L C Rovati, J J Thebault, et al.
Gastroenterology|May 1, 1990
Effect of loxiglumide on gallbladder contractile response to cerulein and food in humansA Malesci, C De Fazio, S Festorazzi, et al.
Arzneimittel-Forschung|January 1, 1979
Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604)A L Rovati, R R Vidal y Plana, P L Casula, et al.
Peptides|November 1, 1986
Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and miceF Makovec, M Bani, R Cereda, et al.
The American Journal of Physiology|December 1, 1986
Structural features of various proglumide-related cholecystokinin receptor antagonistsR T Jensen, Z C Zhou, R B Murphy, et al.
Arzneimittel-Forschung|June 1, 1987
Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistI Setnikar, M Bani, R Cereda, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Arzneimittel-Forschung|September 14, 1999
Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patchI Setnikar, L C Rovati, A Santoro, et al.
Arzneimittel-Forschung|October 1, 1987
Anticholecystokinin activities of loxiglumideI Setnikar, M Bani, R Cereda, et al.
Arzneimittel-Forschung|January 1, 1979
Studies on the mechanism of action of protacine (CR 604), a new non-steroidal anti-inflammatory agentR R Vidal y Plana, F Makovec, A Cifarelli, et al.
Arzneimittel-Forschung|December 22, 1999
Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studiesL C Rovati, K Schmid, G Giacovelli, et al.
Arzneimittel-Forschung|July 1, 1997
Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrixI Setnikar, L C Rovati, J J Thebault, et al.
Gastroenterology|May 1, 1990
Effect of loxiglumide on gallbladder contractile response to cerulein and food in humansA Malesci, C De Fazio, S Festorazzi, et al.
Arzneimittel-Forschung|January 1, 1979
Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604)A L Rovati, R R Vidal y Plana, P L Casula, et al.
Peptides|November 1, 1986
Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and miceF Makovec, M Bani, R Cereda, et al.
The American Journal of Physiology|December 1, 1986
Structural features of various proglumide-related cholecystokinin receptor antagonistsR T Jensen, Z C Zhou, R B Murphy, et al.
Arzneimittel-Forschung|June 1, 1987
Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistI Setnikar, M Bani, R Cereda, et al.
Pageof 10